ACCESSION: MSBNK-SMB_Measured-HSA032P0130006
RECORD_TITLE: Annotated; Pyroglutamic acid; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'HC8-pos_385': {'bp': 3444.0, 'sum': 10114.0}, 'RA17-pos_396': {'bp': 2340.0, 'sum': 6511.0}, 'HC21-pos_386': {'bp': 2141.0, 'sum': 6334.0}, 'RA22-pos_392': {'bp': 1927.0, 'sum': 4706.0}, 'RA13-pos_403': {'bp': 1741.0, 'sum': 4533.0}, 'HC15-pos_367': {'bp': 999.0, 'sum': 2835.0}, 'HC25-pos_366': {'bp': 931.0, 'sum': 2773.0}, 'HC6-pos_877': {'bp': 920.0, 'sum': 2414.0}, 'HC26-pos_1011': {'bp': 259.0, 'sum': 717.0}, 'HC14-pos_864': {'bp': 254.0, 'sum': 712.0}, 'RA8-pos_978': {'bp': 203.0, 'sum': 560.0}}
COMMENT: RETENTION_TIME_STDEV 0.412
COMMENT: PRECURSOR_M/Z_RAW 130.049807
COMMENT: PRECURSOR_M/Z_STDEV 0.000647
COMMENT: PRECURSOR_IN_MS1 mz 130.050379; int 998.999; delta(ppm) 7.898642
COMMENT: PROPOSED_CHARGE_STATE +1; mz 131.052298; int 53.821; cor 0.983
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 3.092; C5H7NO3; [M+H]+; delta(ppm) 3.091993
COMMENT: PROPOSED_MF MS-FINDER 4.758; C5H7NO3; [M+H]+; delta(ppm) 3.063989
COMMENT: PROPOSED_MF SIRIUS5_Sirius 38.534; C5H7NO3; [M+H]+; delta(ppm) 3.063989
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H7NO3; [M+H]+; delta(ppm) 3.063989
COMMENT: PROPOSED_MF SIRIUS6_Sirius 48.313; C5H7NO3; [M+H]+; delta(ppm) 3.063989
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.552; C3H5N4O2; [M+H]+; delta(ppm) 13.388349
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.317; BH3N6O2; [M+H]+; delta(ppm) 83399.904317
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H7NO3; [M+H]+; delta(ppm) 3.063989
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 7.000; ODHCTXKNWHHXJC-VKHMYHEASA-N; C5H7NO3; PYROGLUTAMIC ACID
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; ODHCTXKNWHHXJC-GSVOUGTGSA-N; C5H7NO3; PYROGLUTAMIC ACID
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.583; SKXPOIQAAMIVEO-UHFFFAOYSA-N; [M+H]+; O=C(O)C(=O)N1CCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.533; ODHCTXKNWHHXJC-VKHMYHEASA-N; [M+H]+; OC(=O)[C@@H]1CCC(=O)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.153; HFXAFXVXPMUQCQ-SGAVLPGINA-N; [M+H]+; OC(=O)[C@@H]1CC(=O)CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.139; JYJFNDQBESEHJQ-UHFFFAOYSA-N; [M+H]+; CC1(C)OC(=O)N=C1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.114; CMLUJDMOPDRNRD-NSCUHMNNSA-N; [M+H]+; C\C(=C/C(N)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.670; ODHCTXKNWHHXJC-VKHMYHEASA-N; [M+H]+; Pyroglutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.338; WFOFKRKDDKGRIK-UHFFFAOYNA-N; [M+H]+; Pyrroline hydroxycarboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.206; AOMLMYXPXUTBQH-UHFFFAOYNA-N; [M+H]+; 1-Pyrroline-4-hydroxy-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.883; RBWXRFBKVDBXEG-PWECYVOMNA-N; [M+H]+; UNPD192933
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.817; JYJFNDQBESEHJQ-UHFFFAOYSA-N; [M+H]+; dimethadione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.794; GBYVFZVPFPPNDL-ZNRXLLLOSA-N; [M+H]+; (2S)-6-oxa-1-azabicyclo[3.1.0]hexane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.736; SKXPOIQAAMIVEO-UHFFFAOYSA-N; [M+H]+; 2-(azetidin-1-yl)-2-oxoacetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.716; MGWGVAMJMYUQHT-UHFFFAOYSA-N; [M+H]+; 2-(cyanomethyl)-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.690; DQAKJEWZWDQURW-UHFFFAOYSA-N; [M+H]+; Pyrrolidonecarboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.677; FGWGPHMAARHXDV-UHFFFAOYSA-N; [M+H]+; 3-cyano-4-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.659; CMLUJDMOPDRNRD-NSCUHMNNSA-N; [M+H]+; UNPD152288
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.268; AOFIVJOZERJBKG-UHFFFAOYSA-N; [M+H]+; 5-oxooxolane-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.257; HFXAFXVXPMUQCQ-SGAVLPGINA-N; [M+H]+; 4-oxo-L-proline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.134; LZCXCXDOGAEFQX-UHFFFAOYSA-N; [M+H]+; N-Acryloylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.970; DFQUBYCHLQAFOW-IHWYPQMZSA-N; [M+H]+; (Z)-4-(methylamino)-4-oxobut-2-enoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.786; AZVYYSCOCHRFKW-UHFFFAOYSA-N; [M+H]+; 1-(hydroxymethyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.728; NLKACWKSCREJEL-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-1-methylpyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.727; PBZJGICLVHLSSJ-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.529; VNVPVYUTTNLIEE-NSCUHMNNSA-N; [M+H]+; UNPD35791
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.445; ZIKUNELYRYUYIV-UHFFFAOYSA-N; [M+H]+; 1-methylpyrrole-2,3,5-triol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.344; IYPJQABCLBFGTB-SGAVLPGINA-N; [M+H]+; UNPD193356
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SKXPOIQAAMIVEO-UHFFFAOYSA-N; [M+H]+; 2-(azetidin-1-yl)-2-oxoacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.935; DQAKJEWZWDQURW-UHFFFAOYSA-N; [M+H]+; Pyrrolidonecarboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.897; LZCXCXDOGAEFQX-UHFFFAOYSA-N; [M+H]+; N-Acryloylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.876; ODHCTXKNWHHXJC-VKHMYHEASA-N; [M+H]+; Pyroglutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.874; AOMLMYXPXUTBQH-UHFFFAOYNA-N; [M+H]+; 1-Pyrroline-4-hydroxy-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.869; HFXAFXVXPMUQCQ-SGAVLPGINA-N; [M+H]+; 4-oxo-L-proline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.868; GBYVFZVPFPPNDL-ZNRXLLLOSA-N; [M+H]+; (2S)-6-oxa-1-azabicyclo[3.1.0]hexane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.866; WFOFKRKDDKGRIK-UHFFFAOYNA-N; [M+H]+; Pyrroline hydroxycarboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.803; FGWGPHMAARHXDV-UHFFFAOYSA-N; [M+H]+; 3-cyano-4-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.803; MGWGVAMJMYUQHT-UHFFFAOYSA-N; [M+H]+; 2-(cyanomethyl)-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.789; DFQUBYCHLQAFOW-IHWYPQMZSA-N; [M+H]+; (Z)-4-(methylamino)-4-oxobut-2-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.730; CMLUJDMOPDRNRD-NSCUHMNNSA-N; [M+H]+; UNPD152288
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.722; RBWXRFBKVDBXEG-PWECYVOMNA-N; [M+H]+; UNPD192933
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.667; AOFIVJOZERJBKG-UHFFFAOYSA-N; [M+H]+; 5-oxooxolane-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.574; VNVPVYUTTNLIEE-NSCUHMNNSA-N; [M+H]+; UNPD35791
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.524; NLKACWKSCREJEL-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-1-methylpyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.508; PBZJGICLVHLSSJ-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.502; JYJFNDQBESEHJQ-UHFFFAOYSA-N; [M+H]+; dimethadione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.455; AZVYYSCOCHRFKW-UHFFFAOYSA-N; [M+H]+; 1-(hydroxymethyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.440; ZIKUNELYRYUYIV-UHFFFAOYSA-N; [M+H]+; 1-methylpyrrole-2,3,5-triol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IYPJQABCLBFGTB-SGAVLPGINA-N; [M+H]+; UNPD193356
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.844; ODHCTXKNWHHXJC-VKHMYHEASA-N; [M+H]+; (2S)-5-oxopyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.335; WFOFKRKDDKGRIK-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-3,4-dihydro-2H-pyrrole-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.263; LZCXCXDOGAEFQX-UHFFFAOYSA-N; [M+H]+; 2-(prop-2-enoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; AOMLMYXPXUTBQH-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-3,4-dihydro-2H-pyrrole-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.216; JYJFNDQBESEHJQ-UHFFFAOYSA-N; [M+H]+; 5,5-dimethyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; OQMQLEHOJCDKHA-UHFFFAOYSA-N; [M+H]+; 2-(cyclopropylamino)-2-oxoacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.100; HFXAFXVXPMUQCQ-BYPYZUCNSA-N; [M+H]+; (2S)-4-oxopyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; ADUZMHIDLNHECM-UHFFFAOYSA-N; [M+H]+; 3-methyl-4,5-dihydro-1,2-oxazole-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; PFYZSIGLKDYGAG-UHFFFAOYSA-N; [M+H]+; 2-(4-oxoazetidin-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; GZVHQYZRBCSHAI-UHFFFAOYSA-N; [M+H]+; 5-oxopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; HPQCENXKIPSQSA-UHFFFAOYSA-N; [M+H]+; 2-oxopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; RZRRJTZLVKZGRN-UHFFFAOYSA-N; [M+H]+; 2-(2-oxoazetidin-1-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; AYWACIBPTGPWIN-UHFFFAOYSA-N; [M+H]+; 1-amino-3-oxocyclobutane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; DFQUBYCHLQAFOW-UHFFFAOYSA-N; [M+H]+; 4-(methylamino)-4-oxobut-2-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; SDHXFKBMHSJXHA-UHFFFAOYSA-N; [M+H]+; 1-carbamoylcyclopropane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; RBWXRFBKVDBXEG-DMTCNVIQSA-N; [M+H]+; (2S,3R)-2-amino-3-hydroxypent-4-ynoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; WTFJJYYGWFKOQH-VKHMYHEASA-N; [M+H]+; (4S)-3,4-dimethyl-1,3-oxazolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.794; DZGJLITZBSTRQH-UHFFFAOYSA-N; [M+H]+; 5-methyl-4,5-dihydro-1,2-oxazole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; WIEGQXSJSQWJCK-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-5-methyl-1,3-dioxol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.759; NLKACWKSCREJEL-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-1-methylpyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.738; UFDFFEMHDKXMBG-UHFFFAOYSA-N; [M+H]+; 2-acetamidoprop-2-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.731; CCFXSFYJADFJBM-UHFFFAOYSA-N; [M+H]+; 3-hydroxypiperidine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.725; YHIUSKMZXDIGNJ-UHFFFAOYSA-N; [M+H]+; methyl 4,5-dihydro-1,2-oxazole-5-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.715; FGQJBZHMORPBRR-UHFFFAOYSA-N; [M+H]+; 4-methylmorpholine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.712; DUVOZUPPHBRJJO-UHFFFAOYSA-N; [M+H]+; ethyl 2-isocyanatoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.698; DAWACJOPQDWBME-UHFFFAOYSA-N; [M+H]+; 2,7-dioxa-5-azaspiro[3.4]octan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.695; LIFKTNCXBPSYTQ-UHFFFAOYSA-N; [M+H]+; (2-methoxy-1,3-oxazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.693; AZVYYSCOCHRFKW-UHFFFAOYSA-N; [M+H]+; 1-(hydroxymethyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.692; WZIBHEPNXKTQDS-UHFFFAOYSA-N; [M+H]+; methyl 3-oxoazetidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.684; COCHMAAUXSQMED-UHFFFAOYSA-N; [M+H]+; 3-acetyl-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.679; WAKVYXZJTFOVKC-UHFFFAOYSA-N; [M+H]+; methyl 4-oxoazetidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.678; NFERFOWSDQDXBZ-UHFFFAOYSA-N; [M+H]+; methyl 3-cyano-2-hydroxypropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.615; QLTHBWIACSBXPR-UHFFFAOYSA-N; [M+H]+; methyl 3-isocyanatopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.614; ZYILYULSVKLHKZ-UHFFFAOYSA-N; [M+H]+; methyl 2-isocyanatopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.590; OEYMQQDJCUHKQS-UHFFFAOYSA-N; [M+H]+; (4-oxoazetidin-2-yl) acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.584; RVSDMDPSGIXPSN-UHFFFAOYSA-N; [M+H]+; 2-isocyanatoethyl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.575; MKKLCSLYYDPKIX-UHFFFAOYSA-N; [M+H]+; 4-methylmorpholine-3,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.573; DIIVXOUBNHJXED-UHFFFAOYSA-N; [M+H]+; (3-methoxy-1,2-oxazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.554; SQDRPKFQIUJOBI-GORDUTHDSA-N; [M+H]+; N-[(E)-1-hydroxy-3-oxoprop-1-en-2-yl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.532; VJPPYCQTDYVJKO-UHFFFAOYSA-N; [M+H]+; 3-(1-nitroethylidene)oxetane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; BMFNDMNRYPFUPF-HWKANZROSA-N; [M+H]+; (E)-4-hydroxy-3-nitrosopent-3-en-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -18.315; ODHCTXKNWHHXJC; [M+H]+; Pidolate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.919; RBWXRFBKVDBXEG; [M+H]+; 3-Ethynylserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.498; HFXAFXVXPMUQCQ; [M+H]+; 4-Oxoproline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -160.743; LZCXCXDOGAEFQX; [M+H]+; N-Acryloylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.741; CMLUJDMOPDRNRD; [M+H]+; (Z)-4-amino-2-methyl-4-oxobut-2-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -164.059; WFOFKRKDDKGRIK; [M+H]+; pyrroline-hydroxy-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.501; GZVHQYZRBCSHAI; [M+H]+; 5-Oxo-3-pyrrolidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -186.712; UFDFFEMHDKXMBG; [M+H]+; Acetyldehydroalanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.452; SDHXFKBMHSJXHA; [M+H]+; ACMC-20aowd
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.894; ZYILYULSVKLHKZ; [M+H]+; methyl 2-isocyanatopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.223; DFQUBYCHLQAFOW; [M+H]+; N-Methylmaleamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.905; VNVPVYUTTNLIEE; [M+H]+; methyl 4-amino-4-oxobut-2-enoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.610; ADUZMHIDLNHECM; [M+H]+; 3-methyl-4,5-dihydroisoxazole-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.116; DQAKJEWZWDQURW; [M+H]+; 2-oxopyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.401; SKXPOIQAAMIVEO; [M+H]+; 2-(azetidin-1-yl)-2-oxoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.123; IYPJQABCLBFGTB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.664; BMFNDMNRYPFUPF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.705; AOMLMYXPXUTBQH; [M+H]+; 4-hydroxy-1-pyrroline-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.313; SCXYNWWYWRWGLZ; [M+H]+; methyl 2-(formylamino)acrylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.301; OEYMQQDJCUHKQS; [M+H]+; 4-acetoxy azetidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -247.762; DUVOZUPPHBRJJO; [M+H]+; Ethyl isocyanatoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.869; AOFIVJOZERJBKG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.634; NLKACWKSCREJEL; [M+H]+; ACMC-20apen
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -277.954; AZVYYSCOCHRFKW; [M+H]+; 2, 1-(hydroxymethyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.657; VFERKVPEPDAXQV; [M+H]+; (S)-4-amino-4,5-dihydro-2-furancarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -293.394; JYJFNDQBESEHJQ; [M+H]+; Propazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.776; FGQJBZHMORPBRR; [M+H]+; MIDA anhydride
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.945; ODHCTXKNWHHXJC; [M+H]+; Pidolate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -110.492; ODHCTXKNWHHXJC; [M+H]+; Pidolic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -158.325; OQMQLEHOJCDKHA; [M+H]+; 2-(Cyclopropylamino)-2-oxoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -179.883; CMLUJDMOPDRNRD; [M+H]+; 3-carbamoyl-2-methylprop-2-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.862; AOFIVJOZERJBKG; [M+H]+; 5-oxooxolane-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -187.202; XTRKEAGRGSMYRL; [M+H]+; 4-Isocyanatobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -189.957; FGWGPHMAARHXDV; [M+H]+; 3-Cyano-4-hydroxybutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -193.343; FLPALFSYEPQAMX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -194.040; MGWGVAMJMYUQHT; [M+H]+; 2-(Cyanomethyl)-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -196.754; UFDFFEMHDKXMBG; [M+H]+; 2-Acetamidoacrylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -197.931; ZYILYULSVKLHKZ; [M+H]+; Methyl 2-isocyanatopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.882; ODHCTXKNWHHXJC; [M+H]+; Pidolic Acid
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Pyroglutamic acid, ODHCTXKNWHHXJC-VKHMYHEASA-N; Matching to 7 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (4), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000267;HMDB0000805;HMDB0060262;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C5H7NO3
CH$EXACT_MASS: 129.042593
CH$SMILES: C1CC(=O)N[C@@H]1C(=O)O
CH$IUPAC: InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/t3-/m0/s1
CH$LINK: CHEBI CHEBI:16010
CH$LINK: HMDB HMDB0000267
CH$NAME: 5-Oxoproline
CH$NAME: Pyroglutamic acid
CH$NAME: (2S)-5-oxopyrrolidine-2-carboxylic acid
CH$LINK: INCHIKEY ODHCTXKNWHHXJC-VKHMYHEASA-N
CH$LINK: PUBCHEM CID:7405
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.087
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 130.050268
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-053r-9000000000-4961acf6e60d83bfa8a1
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  39.0228163 126.0599 39.023130 21.6284 79.16 0.7904 8 f{C3H3}/-2.82ppm,p-C2H5N1O3
  41.0386965 477.2880 41.039009 18.2511 181.60 0.9658 11 f{C3H5}/2.92ppm,p-C2H3N1O3
  56.0495108 931.9955 56.049762 16.3605 108.05 1.0000 11 f{C3H6N1}/0.63ppm,p-C2H2O3
  84.0445243 999.0000 84.044731 14.8612 59.39 0.9795 11 f{C4H6N1O1}/1.60ppm,p-C1H2O2
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  39.022816 126.06 126
  41.038697 477.29 477
  56.049511 932.00 931
  84.044524 999.00 999
//
